All companies
Visit website
Puraclenz
OperatingPuraclenz Holdings, Inc.
Healthcare · Technology · Founded 2021
Cleans indoor air and exposed surfaces in homes and businesses at he source
Post-money valuation ⓘ
$29.8M
As of Jun 2022 · from Puraclenz Common Stock 1 · pre-money + amount raised, not a traded price
Total raised
$107,011
Across 1 round since 2022
Latest share price
$8.00
Puraclenz Common Stock 1 offering price
Financials
FY2019–FY2023 · from SEC filings · hover any figure for its source$0
−$204K
2019
$0
2020
$0
2021
$1.9M
−$1.9M
2022
$4.0M
−$1.9M
2023
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2019
FY2020
FY2021
FY2022
FY2023
Income statement
Revenue
$0
$0
$0
$1,880,000
$3,996,000
Cost of goods sold
$0
$0
$0
$1,192,000
$2,696,000
Gross margin
—
—
—
37%
33%
Net income
-$203,954
$0
$0
-$1,887,000
-$1,877,000
Taxes paid
$0
$0
$0
$0
$0
Balance sheet
Cash
$268,991
$0
$0
$242,000
$17,000
Accounts receivable
$0
$0
$0
$162,000
$127,000
Total assets
$2,049,694
$0
$0
$2,888,000
$3,144,000
Short-term debt
$2,247,742
$0
$0
$210,000
$1,237,000
Long-term debt
$0
$0
$0
$904,000
$990,000
Total liabilities
$2,247,742
$0
$0
$1,114,000
$2,227,000
Other
Headcount
—
4
4
—
6
Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Post-money = pre-money + amount raised · caps marked$29.8M
post-money
Puraclenz Common Stock 1
A dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
Fundraising history
Raised $107K / $1.1MInvestors 75Post-money $29.8M
Reg CF annual-report compliance
Not requiredFiled Form C-TR (terminated reporting)
Filed 2 of 5 annual reports (FY2021–FY2025)
75 investors
holder-count proxy
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
Source: ManualCIK 0001915581Share price $8.00
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.